GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 343 filers reported holding GLOBUS MED INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,014,457 | +44.1% | 282,265 | +72.9% | 0.11% | +54.1% |
| Q2 2023 | $9,722,882 | +5.1% | 163,300 | 0.0% | 0.07% | +5.7% |
| Q1 2023 | $9,249,312 | -23.9% | 163,300 | -0.2% | 0.07% | -25.5% |
| Q4 2022 | $12,157,999 | +22.9% | 163,700 | -1.4% | 0.09% | +14.6% |
| Q3 2022 | $9,889,000 | +6.1% | 166,000 | 0.0% | 0.08% | +13.9% |
| Q2 2022 | $9,319,000 | -24.6% | 166,000 | -0.9% | 0.07% | -11.1% |
| Q1 2022 | $12,358,000 | +0.1% | 167,500 | -2.0% | 0.08% | +3.8% |
| Q4 2021 | $12,346,000 | -12.1% | 171,000 | -6.8% | 0.08% | -16.1% |
| Q3 2021 | $14,052,000 | -2.5% | 183,400 | -1.3% | 0.09% | +1.1% |
| Q2 2021 | $14,413,000 | +24.6% | 185,900 | -0.9% | 0.09% | +17.9% |
| Q1 2021 | $11,563,000 | -5.9% | 187,500 | -0.5% | 0.08% | -11.4% |
| Q4 2020 | $12,294,000 | +26.3% | 188,500 | -4.1% | 0.09% | +15.8% |
| Q3 2020 | $9,731,000 | +2.0% | 196,500 | -1.8% | 0.08% | -2.6% |
| Q2 2020 | $9,542,000 | +12.2% | 200,000 | 0.0% | 0.08% | +2.6% |
| Q1 2020 | $8,506,000 | -29.9% | 200,000 | -2.9% | 0.08% | -2.6% |
| Q4 2019 | $12,129,000 | +11.9% | 206,000 | -2.8% | 0.08% | +8.3% |
| Q3 2019 | $10,837,000 | +20.3% | 212,000 | -0.5% | 0.07% | +24.1% |
| Q2 2019 | $9,010,000 | -14.0% | 213,000 | +0.5% | 0.06% | -12.1% |
| Q1 2019 | $10,475,000 | +14.2% | 212,000 | 0.0% | 0.07% | +4.8% |
| Q4 2018 | $9,175,000 | -27.2% | 212,000 | -4.5% | 0.06% | -12.5% |
| Q3 2018 | $12,601,000 | +12.5% | 222,000 | 0.0% | 0.07% | +9.1% |
| Q2 2018 | $11,202,000 | +0.6% | 222,000 | -0.7% | 0.07% | 0.0% |
| Q1 2018 | $11,135,000 | +17.3% | 223,500 | -3.2% | 0.07% | +20.0% |
| Q4 2017 | $9,494,000 | +38.3% | 231,000 | 0.0% | 0.06% | +41.0% |
| Q3 2017 | $6,865,000 | -10.4% | 231,000 | 0.0% | 0.04% | -15.2% |
| Q2 2017 | $7,658,000 | +11.9% | 231,000 | 0.0% | 0.05% | +15.0% |
| Q1 2017 | $6,842,000 | +19.6% | 231,000 | +0.2% | 0.04% | +17.6% |
| Q4 2016 | $5,719,000 | +30.6% | 230,500 | +18.8% | 0.03% | +30.8% |
| Q3 2016 | $4,379,000 | +162.5% | 194,000 | +177.1% | 0.03% | +160.0% |
| Q2 2016 | $1,668,000 | +13.2% | 70,000 | +12.9% | 0.01% | +11.1% |
| Q1 2016 | $1,473,000 | +60.5% | 62,000 | +87.9% | 0.01% | +50.0% |
| Q4 2015 | $918,000 | – | 33,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |